Download presentation
Presentation is loading. Please wait.
1
A Case of Atypical Carcinoid: Harboring Variant 3a/b EML4–ALK Rearrangement
Aya Fukuizumi, MD Journal of Thoracic Oncology Volume 10, Issue 10, Pages e104-e106 (October 2015) DOI: /JTO Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
2
FIGURE 1 A and B, Computed tomography (CT) scan of thorax before initiation of crizotinib; C, positron emission tomography–CT scan before initiation of crizotinib; D, CT scan of thorax after 18 days of treatment with crizotinib. Journal of Thoracic Oncology , e104-e106DOI: ( /JTO ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
3
FIGURE 2 Histopathological image of the transbronchial biopsy specimen. The result of immunoreactivity was positive for chromogranin A, synaptophysin, and CD56. Journal of Thoracic Oncology , e104-e106DOI: ( /JTO ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
4
FIGURE 3 EML4–ALK fusion gene in all four examinations (immunohistochemistry/fluorescence in situ hybridization/reverse transcriptase-polymerase chain reaction/next generation sequencer). Journal of Thoracic Oncology , e104-e106DOI: ( /JTO ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.